Özet:

Mucormicose is an invasive opportunistic fungal infection that is rare and often seen with high mortality. Correction of the underlying disease is the basis for the treatment of aggressive surgical debridman and systemic amphoteris B. Although the factor is widely found in nature, it often creates a disease in individuals with an immuun system that is suppressed or uncontrolled diabetes. Invasive fungal infection incidence is high in patients with hematopoetic root cell transplant (HKHT), while the incidence is lower in patients with only chemotherapy. In literature there are very few reports of the fact that mucormicosis develops in multiple myeloma patients who only receive chemotherapy. This article aims to present the phenomenon of rinoserebral mucous disease developing in a patient with multiple myeloma. During the last period, the incidence of mucous cystitis has increased due to the increase in the number of patients with immunosuppression. The purpose of this presentation is to note that non-diabetic and non-hematopoetic root cell transplant may also develop mucous myeloma in patients with multiple myeloma and that the treatment of invasive fungal infections in immunosuppressive cases is very difficult.

Anahtar Kelimeler: